Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Sarcoma
>>
Epigenetics
>>
Phase 2
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
2
4
6
8
10
12
14
16
18
20
Zolinza
(vorinostat) / Merck (MSD)
azacitidine
/ Generic mfg.
Farydak
(panobinostat) / Secura Bio
Istodax
(romidepsin) / Astellas, BMS
Beleodaq
(belinostat) / Aurobindo, Assertio
Epidaza
(chidamide) / Chipscreen
adavosertib
(AZD1775) / AstraZeneca
abexinostat
(CG-781) / Xynomic
decitabine
/ Generic mfg.
tinostamustine
(EDO-S101) / Mundipharma
Idhifa
(enasidenib) / BMS, Servier
Inqovi
(decitabine/cedazuridine) / Otsuka
ONCT-216
/ Oncternal Therap
guadecitabine
(SGI-110) / Otsuka
mocetinostat
(MGCD0103) / Otsuka, BMS
seclidemstat
(SP2577) / Salarius
BI2536
/ Boehringer Ingelheim
Jingzhuda
(entinostat) / EOC Pharma, EddingPharm
Rezlidhia
(olutasidenib) / Rigel
Welireg
(belzutifan) / Merck (MSD)
nanatinostat
(VRx-3996) / Viracta Therap
pracinostat
(SB939) / Helsinn, MEI, Menarini
